Abou-el-enein banner image

CHLA, Keck School, Keck Medicine and USC Norris partner on cell therapy program as construction on new facility begins

The essence of translational medicine is taking an idea from the drawing board and “translating” it into a real-world treatment that helps patients. The winding road of that process takes plenty of time, money and expertise, so it makes sense to place it all under one roof. USC and Children’s Hospital Los Angeles (CHLA) are…Continue Reading CHLA, Keck School, Keck Medicine and USC Norris partner on cell therapy program as construction on new facility begins

Mohamed Abou-el-Enein named Executive Director of USC/CHLA Cell Therapy Program

Mohamed Abou-el-Enein, MD, PhD, MSPH, has joined the Keck School of Medicine as the inaugural Executive Director of the Joint USC/CHLA Cell Therapy Program. He began his post Jan. 4. Abou-el-Enein will also serve as Medical Director of the new cGMP facility for cell and gene therapy that is under construction in the Norris Research…Continue Reading Mohamed Abou-el-Enein named Executive Director of USC/CHLA Cell Therapy Program